26choiceM

Dow Jones vs. S&P 500: What UnitedHealth’s volatility reveals for investors

Charu Chanana 400x400
Charu Chanana

Chief Investment Strategist

Key points:

  • UnitedHealth volatility highlights a key difference between the Dow and the S&P 500. UnitedHealth’s sharp decline and subsequent rebound had an outsized impact on the Dow, while the S&P 500 remained relatively unaffected, underscoring how index structure drives performance sensitivity.
  • The Dow is price-weighted; the S&P 500 is market-cap weighted. In the Dow, high-priced stocks like UNH can disproportionately move the index, even when most other components are flat or rising. In contrast, the S&P 500 spreads influence across a broader base, muting the effect of individual stock swings.
  • For long-term investors, the S&P 500 offers diversified, growth-oriented exposure while Dow offers a defensive tilt. The Dow’s construction makes it more sensitive to moves in a few names but also gives it a tilt toward value and defensive sectors—making it useful as a tactical complement in more volatile or late-cycle environments.


Note: This content is marketing material.

 

Last week, UnitedHealth Group (UNH) took center stage in U.S. equity markets—not for its gains, but for a sharp selloff that sent the stock nearly 23% lower. The move weighed heavily on the Dow Jones Industrial Average, where UNH holds significant influence due to the index’s price-weighted methodology.

The episode serves as a timely reminder of the structural differences between the Dow Jones and the S&P 500—and why understanding those differences is critical for investors making allocation decisions.

Why did UnitedHealth fall?

The stock declined sharply amid a convergence of negative developments:

  • Reports emerged that the U.S. Department of Justice had launched a criminal investigation into UnitedHealth’s Medicare Advantage billing practices.
  • The company withdrew its 2025 financial guidance, citing rising medical costs, particularly from newer Medicare Advantage patients.
  • The abrupt resignation of CEO Andrew Witty added to investor concerns and led to a broader selloff.

The stock ended the week down 23%, with most of the damage occurring on 13 May, when UNH fell 18% in a single day. You can read more about the great UnitedHealth collapse in this article: How a healthcare titan lost 54% in weeks

Why index construction matters

UnitedHealth is a constituent of both the Dow Jones Industrial Average and the S&P 500, but the way these indices are constructed means the impact of UNH’s moves is felt very differently.

The Dow is price-weighted, meaning a stock’s influence is based on its share price. UNH is one of the highest-priced stocks in the index, so large moves in its share price can swing the Dow significantly. On 13 May, despite half the Dow’s components closing higher, the index still fell around 270 points—with UNH accounting for over 400 points of downward pressure, according to our estimates.

By contrast, the S&P 500 is market-cap weighted, which spreads exposure more broadly across sectors and companies. While UNH’s sharp drop was felt, the S&P 500 still managed to close up 0.7%, lifted by gains in large-cap tech names. Notably, more than half of the index’s components ended the day in the red—underscoring how market-cap weighting can mute the impact of single-stock declines.

This dynamic played out in reverse just days later. On 19 May, UNH rebounded strongly—rising 8.2% in a single session. The Dow, with its heavy price-based exposure to UNH, gained 0.3%. The S&P 500, however, rose only 0.09%, again illustrating how index structure influences performance.


Index construction at a glance

Dow Jones Industrial Average

  • Composed of 30 large-cap U.S. companies.
  • Price-weighted: higher-priced stocks carry more index weight.
  • Tilts toward healthcare, industrials, and financials.
  • Highly sensitive to single-stock moves, as demonstrated by UNH’s drag.

S&P 500

  • Composed of 500 large-cap U.S. companies.
  • Market-cap weighted: larger companies by value have more influence.
  • Heavily weighted in tech and growth sectors.
  • Better represents broad market sentiment and reduces concentration risk.

Strategic implications for investors

Impact of individual stocks:

  • Due to the DJIA's price-weighted structure, high-priced stocks like UNH can disproportionately influence the index's performance.
  • The S&P 500's market-cap weighting dilutes the impact of any single stock, offering more diversified exposure.

Sector rotation considerations:

  • If there's a market rotation from technology to sectors like healthcare, the DJIA may benefit more due to its sector composition.
  • Investors anticipating such rotations might consider increasing exposure to the DJIA or sector-specific ETFs.
  • But in a tech-led rally, the S&P 500 is likely to lead.

Diversification and stability:

  • The S&P 500's broader base provides more stability and is less susceptible to volatility from individual stock movements.
  • For long-term investors seeking diversified exposure, the S&P 500 remains a foundational choice.
  • Holding both indices, or using ETFs that balance between value and growth sectors, may help navigate volatility and sector rotations more effectively.

Portfolio allocation considerations

Short-term tactical moves:

Investors looking to capitalize on potential rebounds in specific sectors, like healthcare, might consider targeted investments in the DJIA or sector-specific ETFs.

Long-term stability:

Maintaining a core allocation to the S&P 500 ensures broad market exposure and mitigates risks associated with individual stock volatility.

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.


Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.